NONPEPTIDIC INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE .2. DESIGN, SYNTHESIS, AND IN-VITRO ACTIVITY OF A SERIES OF 3-AMINO-6-ARYLOPYRIDIN-2-ONE TRIFLUOROMETHYL KETONES

被引:33
作者
DAMEWOOD, JR
EDWARDS, PD
FEENEY, S
GOMES, BC
STEELMAN, GB
TUTHILL, PA
WILIIAMS, JC
WARNER, P
WOOLSON, SA
WOLANIN, DJ
VEALE, CA
机构
[1] ZENECA INC,DEPT MED CHEM,ZENECA PHARMACEUT GRP,BUSINESS UNIT,WILMINGTON,DE 19897
[2] ZENECA INC,DEPT PHARMACOL,ZENECA PHARMACEUT GRP,BUSINESS UNIT,WILMINGTON,DE 19897
关键词
D O I
10.1021/jm00046a015
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of potent nonpeptidic inhibitors of the enzyme human leukocyte elastase (HLE) is reported. These inhibitors contain a 3-amino-2-pyridone ring as a central template in which the pyridone carbonyl and 3-position NH group are thought to form important hydrogen bonding interactions with the Val-216 residue of HLE. Substitution of the 6-position of the pyridone ring by various alkyl and aryl groups was found to afford increases in the in vitro potency of these inhibitors. A 6-position phenyl group, compound 10f, was found to result in a large increase in binding affinity, which was not obtained when the phenyl group was placed in either the 4- or 5-position of the molecule. Compound 10f was found to have good selectivity for HLE over other proteolytic enzymes, with the exception of bovine pancreatic chymotrypsin (BPC). Substitution of the 6-phenyl group in these molecules was found to decrease binding affinity for BPC without adversely affecting affinity for HLE.
引用
收藏
页码:3303 / 3312
页数:10
相关论文
共 42 条
[1]  
BERGESON S, 1990, Patent No. 4910190
[2]  
BERNSTEIN PB, J MED CHEM
[3]  
BERNSTEIN PR, 1992, Patent No. 509769
[4]   X-RAY CRYSTAL-STRUCTURE OF THE COMPLEX OF HUMAN-LEUKOCYTE ELASTASE (PMN ELASTASE) AND THE 3RD DOMAIN OF THE TURKEY OVOMUCOID INHIBITOR [J].
BODE, W ;
WEI, AZ ;
HUBER, R ;
MEYER, E ;
TRAVIS, J ;
NEUMANN, S .
EMBO JOURNAL, 1986, 5 (10) :2453-2458
[5]   HUMAN-LEUKOCYTE AND PORCINE PANCREATIC ELASTASE - X-RAY CRYSTAL-STRUCTURES, MECHANISM, SUBSTRATE-SPECIFICITY, AND MECHANISM-BASED INHIBITORS [J].
BODE, W ;
MEYER, E ;
POWERS, JC .
BIOCHEMISTRY, 1989, 28 (05) :1951-1963
[6]   DETERMINING ATOM-CENTERED MONOPOLES FROM MOLECULAR ELECTROSTATIC POTENTIALS - THE NEED FOR HIGH SAMPLING DENSITY IN FORMAMIDE CONFORMATIONAL-ANALYSIS [J].
BRENEMAN, CM ;
WIBERG, KB .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1990, 11 (03) :361-373
[7]  
BROOKS CL, 1988, PROTEINS THEORETICAL
[8]   DESIGN OF ORALLY-ACTIVE, NONPEPTIDIC INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE [J].
BROWN, FJ ;
ANDISIK, DW ;
BERNSTEIN, PR ;
BRYANT, CB ;
CECCARELLI, C ;
DAMEWOOD, JR ;
WOOLSON, SA ;
EDWARDS, PD ;
EARLEY, RA ;
FEENEY, S ;
GREEN, RC ;
GOMES, B ;
KOSMIDER, BJ ;
KRELL, RD ;
SHAW, A ;
STEELMAN, GB ;
THOMAS, RN ;
VACEK, EP ;
VEALE, CA ;
TUTHILL, PA ;
WARNER, P ;
WILLIAMS, JC ;
WOLANIN, DJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (09) :1259-1261
[9]   FREE-ENERGY CALCULATIONS ON BINDING AND CATALYSIS BY ALPHA-LYTIC PROTEASE - THE ROLE OF SUBSTRATE SIZE IN THE P1 POCKET [J].
CALDWELL, JW ;
AGARD, DA ;
KOLLMAN, PA .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1991, 10 (02) :140-148
[10]  
CECCARELLI C, COMMUNICATION